Salim Shah, PhD, JD
Sarfez Pharmaceuticals, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Salim Shah, PhD, JD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:19 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07046975 · Bioavailability and Bioequivalence Study of Extended Release Torsemide and SpironolactoneSarfez Pharmaceuticals, Inc. · completed · Bioavailability Heathy Volunteers · study director
- Ph3NCT07043634 · A Study to Evaluate the Effect of Food or no Food on the Bioavailability of an Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult SubjectsSarfez Pharmaceuticals, Inc. · completed · Bioavailability Heathy Volunteers · study chair
- Ph3NCT07015671 · Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy SubjectsSarfez Pharmaceuticals, Inc. · completed · Bioequivalence Study in Healthy Subjects, PK/PD · study chair
- Ph4NCT06995144 · Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart FailureSarfez Pharmaceuticals, Inc. · withdrawn · Heart Failure, Edema, Pulmonary Congestion · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:19 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.